| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Stapley Marc | Chief Executive Officer, Director | 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO | /s/ Jonathan Wygant, as attorney-in-fact | 02 Mar 2026 | 0001539796 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VCYT | Common Stock | Award | $0 | +139,074 | +44% | $0.000000 | 458,373 | 26 Feb 2026 | Direct | F1, F2 |
| transaction | VCYT | Common Stock | Tax liability | $1,388,839 | -35,841 | -7.8% | $38.75 | 422,532 | 26 Feb 2026 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 26, 2026, upon the certification by the Board of Directors of the Issuer of the achievement of the performance goals set forth therein. Of such PSUs, 70,239 PSUs vested on February 26, 2026, and the remaining 68,835 PSUs will vest on December 2, 2026, subject to the Reporting Person's continuous service to the Issuer through such date. |
| F2 | Includes 696 shares of common stock purchased on January 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. |
| F3 | Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale. |